Skip to Content

Pharmaceuticals, Volume 8, Issue 3

2015 September - 13 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (13)

  • Article
  • Open Access
84 Citations
13,531 Views
27 Pages

Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition

  • Nicholas E. Thomford,
  • Kevin Dzobo,
  • Denis Chopera,
  • Ambroise Wonkam,
  • Michelle Skelton,
  • Dee Blackhurst,
  • Shadreck Chirikure and
  • Collet Dandara

21 September 2015

The most accessible points of call for most African populations with respect to primary health care are traditional health systems that include spiritual, religious, and herbal medicine. This review focusses only on the use of herbal medicines. Most...

  • Review
  • Open Access
19 Citations
8,770 Views
17 Pages

17 September 2015

Recently, ketamine has been demonstrated to exert rapid-acting antidepressant effects in patients with depression, including those with treatment-resistant depression, and this discovery has been regarded as the most significant advance in drug devel...

  • Review
  • Open Access
20 Citations
12,630 Views
30 Pages

17 September 2015

There has been a recent emergence of novel targeted agents for treatment of Hodgkin and non-Hodgkin lymphoma. In particular, antibodies and antibody-drug conjugates directed against surface antigens, agents that block immune checkpoint pathways, and...

  • Review
  • Open Access
85 Citations
12,738 Views
31 Pages

9 September 2015

Bacteriophages are the viruses of bacteria. In the guise of phage therapy they have been used for decades to successfully treat what are probable biofilm-containing chronic bacterial infections. More recently, phage treatment or biocontrol of biofilm...

  • Review
  • Open Access
66 Citations
10,877 Views
34 Pages

9 September 2015

Bacteriophages, the viruses that infect bacteria, have for decades been successfully used to combat antibiotic-resistant, chronic bacterial infections, many of which are likely biofilm associated. Antibiotics as anti-biofilm agents can, by contrast,...

  • Article
  • Open Access
13 Citations
5,913 Views
13 Pages

7 September 2015

Patients with inflammatory bowel disease (IBD) often have associated conditions, for which anti-inflammatory medication with cyclo-oxygenase (COX) inhibitors may be helpful. The current evidence is conflicting regarding the role of COX-inhibitors in...

  • Article
  • Open Access
27 Citations
6,903 Views
21 Pages

13 August 2015

Candida albicans is the most prevalent cause of fungal infections and treatment is further complicated by the formation of drug resistant biofilms, often on the surfaces of implanted medical devices. In recent years, the incidence of fungal infection...

  • Article
  • Open Access
15 Citations
6,637 Views
9 Pages

4 August 2015

Introduction: Ruthenium 360 (Ru360) has been shown to induce cardioprotective mechanisms in perfused hearts. The agent is a specific blocker of the main cardiac mitochondrial uptake mechanism, the mitochondrial calcium uniporter (MCU). UCP2, a mitoc...

  • Review
  • Open Access
12 Citations
7,830 Views
19 Pages

31 July 2015

Phosphoprotein enriched in astrocytes, 15 KDa (PEA-15), a ubiquitously expressed small protein in all mammals, is known for decades for its potent interactions with various protein partners along distinct biological pathways. Most notable interacting...

  • Article
  • Open Access
13 Citations
9,407 Views
20 Pages

29 July 2015

The first-in-human phase 1 clinical radioimmunotherapy (RIT) trial with 212Pb-1,4,7,10-tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)-cyclododecane-trastuzumab (212Pb-TCMC-trastuzumab) was completed in October 2014 as a joint effort at the University o...

  • Article
  • Open Access
24 Citations
7,849 Views
19 Pages

Toxicological Studies of 212Pb Intravenously or Intraperitoneally Injected into Mice for a Phase 1 Trial

  • Diane E. Milenic,
  • Alfredo A. Molinolo,
  • María S. Solivella,
  • Eileen Banaga,
  • Julien Torgue,
  • Sarah Besnainou,
  • Martin W. Brechbiel and
  • Kwamena E. Baidoo

24 July 2015

Faced with the novelty of a 212Pb-labeled monoclonal antibody (mAb) for clinical translation, concerns were expressed by the Food and Drug Administration (FDA) regarding 212Pb prematurely released from the mAb-chelate conjugate. The objective of this...

  • Review
  • Open Access
193 Citations
19,937 Views
50 Pages

13 July 2015

The purpose of this paper is to introduce and highlight a few classes of traditional antimicrobial peptides with a focus on structure-activity relationship studies. After first dissecting the important physiochemical properties that influence the ant...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247